Evidence
Front Transplant. 2023 Jul 3;2:1178452. doi: 10.3389/frtra.2023.1178452. eCollection 2023.
ABSTRACT
The first successful human liver transplant (LT) was done over 60 years ago; since the early pioneering days, this procedure has become a routine treatment with excellent outcomes for the great majority of recipients. Over the last six decades, indications have evolved. Use of LT for hepatic malignancy is becoming less common as factors that define a successful outcome are being increasingly defined, and alternative therapeutic options become available. Both Hepatitis B and C virus associated liver disease are becoming less common indications as medical treatments become more effective in preventing end-stage disease. Currently, the most common indications are alcohol-related liver disease and metabolic associated liver disease. The developing (and controversial) indications include acute on chronic liver failure, alcoholic hepatitis and some rarer malignancies such as non-resectable colorectal cancer liver metastases, neuroendocrine tumours and cholangiocarcinoma. Candidates are becoming older and with greater comorbidities, A relative shortage of donor organs remains the greatest cause for reducing access to LT; therefore, various countries have developed transparent approaches to allocation of this life saving and life enhancing resource. Reliance on prognostic models has gone some way to improve transparency and increase equity of access but these approaches have their limitations.
PMID:38993916 | PMC:PMC11235376 | DOI:10.3389/frtra.2023.1178452
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
The evolution of the liver transplant candidate
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Venomous Snakebite Encounters in Liver Transplant Recipients: A Case Report and Review of Relevant Literature
- Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
- Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention
- A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse
- Long-Term Cognitive Outcomes and Associated Quality of Life of Young Adults Who Experienced Liver Transplantation in Early Childhood
- Long-Term Cognitive Outcomes and Associated Quality of Life of Young Adults Who Experienced Liver Transplantation in Early Childhood
- Postoperative Delirium Screening Characteristics in Pediatric Intestinal, Liver, and Renal Transplant Recipients: Single-Center Retrospective Cohort Study
- Opioid use and risks in liver transplant candidates and recipients
- Are face transplant candidates choosing autonomously? A preliminary method to evaluate autonomous choosing in psychosocial and bioethical assessments
- H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure
- The Frequency and Impact of Adverse Childhood Experiences on Mood, Alcohol Relapse, and Outcomes in Liver Transplantation: A Retrospective Cohort Study
- Liver transplantation as treatment for acetaminophen poisoning
- Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy
- Outcomes of Combined Liver-Kidney Transplantation - Single Center Experience
- Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study
- Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma
- Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights
- Utility of scores to predict alcohol use after liver transplant (lt): take them with a grain of salt
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Over Three Decades of Growth Hormone Treatment in Children With Chronic Kidney Disease-Associated Growth Failure Before and After Kidney Transplantation
- Transplant-associated Altered Mentation and Encephalopathy (TAME): A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines
- Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting
- Research advances in serum chitinase-3-like protein 1 in liver fibrosis
- Research advances in serum chitinase-3-like protein 1 in liver fibrosis
- Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment
- Generation and characterization of mature hepatocyte organoids for liver metabolic studies
- The gut-liver axis in fatty liver disease: role played by natural products
- Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets
- Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment
- Review article: Hepatic steatosis and its associations with acute and chronic liver diseases
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation
- The role and mechanism of SUMO modification in liver disease
- Role of prostaglandin E2 and its receptors in chronic liver disease
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- Management of ectopic variceal bleeding with transjugular intrahepatic portosystemic shunt: a systematic review of case reports
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
- Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease
- Evaluation of Google Search Trends for Liver Diseases in Europe
- Time trends in preemptive kidney transplantation in Europe: an era registry study
- Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook
- Barriers to liver transplant referral in safety net settings: A national provider survey
- Hepatic compartment syndrome, a rare complication after any liver insult or liver transplantation: Three case reports and literature review
- FGL1 and FGL2: emerging regulators of liver health and disease
- Educational Needs of the Adolescent Transplant Recipient: A Developmental Approach to Understanding Transplant
- Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis
- Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
- Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study
- New nomenclature for fatty liver disease
- Psychological assessment of patients on the heart transplant waiting list: A single center experience
- Psychological assessment of patients on the heart transplant waiting list: A single center experience
- Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?
- Angiocrine signaling in sinusoidal homeostasis and liver diseases
- The roles and potential mechanisms of plant polysaccharides in liver diseases: a review
- CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
- AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training
Evidence Blueprint
The evolution of the liver transplant candidate
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The evolution of the liver transplant candidate
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Venomous Snakebite Encounters in Liver Transplant Recipients: A Case Report and Review of Relevant Literature
- Metabolic Disorders in Liver Transplant Recipients: The State of the Art
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
- Pancreatic steatosis is an independent risk factor for post-transplant diabetes mellitus in kidney transplant patients
- Outcomes and Resource Utilization in Liver Transplant Recipients Who Underwent Expedited Transplant Evaluation
- Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention
- A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse
- Long-Term Cognitive Outcomes and Associated Quality of Life of Young Adults Who Experienced Liver Transplantation in Early Childhood
- Long-Term Cognitive Outcomes and Associated Quality of Life of Young Adults Who Experienced Liver Transplantation in Early Childhood
- Inferior Liver Transplant Outcomes during early COVID-19 pandemic in United States
- The progression of hepatorenal syndrome-acute kidney injury in acute alcohol-associated hepatitis: renal outcomes after liver transplant
- Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil
- Postoperative Delirium Screening Characteristics in Pediatric Intestinal, Liver, and Renal Transplant Recipients: Single-Center Retrospective Cohort Study
- Health status of patients with liver transplantation by alcohol-related disease vs another etiology: a cohort study
- Transplant and non-transplant HCC patients at a single institution
- Prevalence of cognitive impairment in liver transplant recipients
- Outcomes of re-referrals of patients with alcohol-related liver disease who were previously declined for liver transplantation
- Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease
- Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition?
- Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians
- Psychosocial conditions of children after liver transplant: Post-traumatic stress, depression, and anxiety
- Opioid use and risks in liver transplant candidates and recipients
- Are face transplant candidates choosing autonomously? A preliminary method to evaluate autonomous choosing in psychosocial and bioethical assessments
- Current Status of Living Donor Liver Transplantation: Impact, Advantages, and Challenges
- Management of alcoholic hepatitis: A clinical perspective
- H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure
- The Frequency and Impact of Adverse Childhood Experiences on Mood, Alcohol Relapse, and Outcomes in Liver Transplantation: A Retrospective Cohort Study
- Liver transplantation as treatment for acetaminophen poisoning
- COVID-19 in Individuals with Chronic Liver Diseases
- Biguanides and glucagon like peptide 1 receptor agonists in the amelioration of post liver transplant weight gain; a scoping review of the mechanism of action, safety and efficacy
- Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis
- Clinical Utility and Impact of Phosphatidylethanol (PEth) Testing in Liver Transplantation Evaluations
- Adjustment disorder and its risk factors during the solid organ pre-transplant period for children: A retrospective analysis of the last 10 years
- Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis
- Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- Life-Threatening Electrical Storm Following Liver Transplantation: A Case Report
- Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan
- A comparison between patients with various etiologies of cirrhosis and examination of cardiac risk factors limiting survival to liver transplantation
- Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis
- The effect of liver disease on hepatic microenvironment and implications for immune therapy
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Outcomes of Combined Liver-Kidney Transplantation - Single Center Experience
- Adherence to therapy among liver transplant patients as related to depression, anxiety, acceptance of the disease, and social support
- Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
- Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study
- Concept and risk factors of alcohol relapse in liver transplant recipients with alcohol-related aetiologies: A scoping review
- Role of NRF2 and reactive aldehydes in acute cellular rejection in liver transplant recipients
- Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models
- Do pre-transplant cultural factors predict health-related quality of life after kidney transplantation?
- International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study
- Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma
- Prevalence and spectrum of infectious and inflammatory dermatologic conditions occurring in pediatric heart transplant patients on a predominantly mTOR-based immune suppressive regimen: A retrospective chart review
- The First Successful Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report
- Disparities in Liver Transplantation Rates and Outcomes Among Adults with and without Mental Illnesses
- Cancer Therapy-related Hepatic Injury in Children: Imaging Review from the Pediatric LI-RADS Working Group
- Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights
- NASH drug treatment development: challenges and lessons
- The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
- APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
- Alcohol Consumption Post-Liver Transplantation: A Cross-Sectional Study
- Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study